SCHEMBL21494624

SCHEMBL21494624

CC(C)C(NC(=O)c1ccc(NC(=O)Cc2c(N)nc(N)[nH]c2=O)cn1)C(=O)O

nearest known ligand 1.00 ✓ in ChEMBL — recovers established targets

Predicted protein targets (top 4)

geneUniProtsupporting neighboursconfidence
▸ FPR2 P25090 19/20 1.00
▸ AKR1B1 P15121 1/20 0.52
▸ MTHFD1 P11586 1/20 0.51
▸ MTHFD2 P13995 1/20 0.51

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL21494623 1.00 FPR2 (1.00) FPR2AKR1B1MTHFD1MTHFD2
SCHEMBL30106777 1.00 FPR2 (1.00) FPR2AKR1B1MTHFD1MTHFD2
SCHEMBL21494679 0.84 FPR2 (1.00) FPR2MTHFD1MTHFD2
SCHEMBL31657846 0.84 FPR2 (1.00) FPR2MTHFD1MTHFD2
SCHEMBL21494675 0.84 FPR2 (1.00) FPR2MTHFD1MTHFD2
SCHEMBL21494695 0.83 FPR2 (1.00) FPR2AKR1B1MTHFD1MTHFD2
SCHEMBL30106798 0.83 FPR2 (1.00) FPR2AKR1B1MTHFD1MTHFD2
SCHEMBL21494697 0.83 FPR2 (1.00) FPR2AKR1B1MTHFD1MTHFD2
SCHEMBL21494625 0.83 FPR2 (0.71) FPR2MTHFD1MTHFD2
Hydrochloric Acid SCHEMBL21494810 0.83 FPR2 (0.98) FPR2MTHFD1MTHFD2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-3781554-A1 2,6-DIAMINO-3,4-DIHYDROPYRIMIDIN-4-ONE DERIVATIVES AND USE THEREOF IN THERAPY Thomas Helledays stiftelse för medicinsk forskning (SE) 2021-02-24 — — EP claimed
WO-2019201991-A1 2,6-DIAMINO-3,4-DIHYDROPYRIMIDIN-4-ONE DERIVATIVES AND USE THEREOF IN THERAPY THOMAS HELLEDAYS STIFTELSE FÖR MEDICINSK FORSKNING (SE) 2019-10-24 — — WO claimed
CN-112218858-B 2, 6-Diamino-3, 4-dihydropyrimidin-4-one derivatives and their use in therapy 托马斯·黑勒戴药物研究基金会 2024-06-18 — — CN disclosed
Send feedback